&NMN HIGH PERFORMER
Regular price
RM4,200.00 MYR
type
- Take 1 sachet (3 capsules) per day with water or lukewarm water.
- Remember: A balanced diet is key. Aim to include a variety of main dishes, side dishes, and staples in your meals for optimal nutrition.
- Storage Instructions: Store at room temperature, away from direct sunlight.
Per 1 sachet (3 capsules, 930 mg):
- Energy: 3.54 kcal
- Protein: 0.13 g
- Fat: 0.04 g
- Carbohydrates: 0.67 g
- Salt equivalent: 0.009 g
- Product Name: Processed Food Containing Nicotinamide Mononucleotide (NMN) and Other Ingredients
- Contents：Per 1 sachet(3 capsules, 930 mg)
- Country of Origin：Made in Japan
- Ingredients
- White Capsules: β-Nicotinamide Mononucleotide (Manufactured in Japan), Starch / HPMC, Calcium Stearate, Silicon Dioxide
- Yellow Capsules: Chrysanthemum Flower Extract Powder (Chrysanthemum Flower Extract, Starch Decomposition Product) (Manufactured in Japan), Starch / HPMC, Quercetin, Sunflower Lecithin, Calcium Stearate, Silicon Dioxide
- Net Weight：27.90 g [30 sachets × 3 capsules (930 mg) per sachet]
- Please check the ingredients list carefully. Do not consume if you have any food allergies to the listed ingredients. In rare cases, this product may not suit your body type or condition. If you experience any discomfort, please discontinue use.
- If you are currently taking medication or under medical care, please consult your doctor before use.
- This product is not intended to diagnose, treat, cure, or prevent any disease. Excessive consumption will not improve health or cure illnesses. Please adhere to the recommended daily intake.
- Keep out of reach of children.
- Product color may change depending on storage conditions. This does not affect the quality of the product.
Regular price
RM4,200.00 MYR
type
- Take 1 sachet (3 capsules) per day with water or lukewarm water.
- Remember: A balanced diet is key. Aim to include a variety of main dishes, side dishes, and staples in your meals for optimal nutrition.
- Storage Instructions: Store at room temperature, away from direct sunlight.
Per 1 sachet (3 capsules, 930 mg):
- Energy: 3.54 kcal
- Protein: 0.13 g
- Fat: 0.04 g
- Carbohydrates: 0.67 g
- Salt equivalent: 0.009 g
- Product Name: Processed Food Containing Nicotinamide Mononucleotide (NMN) and Other Ingredients
- Contents：Per 1 sachet(3 capsules, 930 mg)
- Country of Origin：Made in Japan
- Ingredients
- White Capsules: β-Nicotinamide Mononucleotide (Manufactured in Japan), Starch / HPMC, Calcium Stearate, Silicon Dioxide
- Yellow Capsules: Chrysanthemum Flower Extract Powder (Chrysanthemum Flower Extract, Starch Decomposition Product) (Manufactured in Japan), Starch / HPMC, Quercetin, Sunflower Lecithin, Calcium Stearate, Silicon Dioxide
- Net Weight：27.90 g [30 sachets × 3 capsules (930 mg) per sachet]
- Please check the ingredients list carefully. Do not consume if you have any food allergies to the listed ingredients. In rare cases, this product may not suit your body type or condition. If you experience any discomfort, please discontinue use.
- If you are currently taking medication or under medical care, please consult your doctor before use.
- This product is not intended to diagnose, treat, cure, or prevent any disease. Excessive consumption will not improve health or cure illnesses. Please adhere to the recommended daily intake.
- Keep out of reach of children.
- Product color may change depending on storage conditions. This does not affect the quality of the product.
Beyond Imagination,
Next Generation※1
Concept Model
※1 Compared to our own products
250 mg Clinical Dosage of NMN Proven Effective in Human Trials
We adhere to 250 mg of NMN—a dosage widely adopted in numerous clinical trials, offering the potential for sustained NAD+ support.
These days, you might see many high-dose NMN supplements online. While future research may explore higher doses, we remain convinced that, at this stage and for consistent daily intake, 250 mg is the appropriate (and reliable) amount.
Enhance the efficiency of the 250 mg NMN
Throughout years of dedicated research, our primary focus was maximizing NMN’s inherent potential to deliver energy support for healthy aging. After meticulously reviewing a wide range of global studies and research, we identified plant-derived support ingredients that support NMN’s conversion into NAD+. By selecting the right ingredients and formulating them in optimal amounts, we successfully refined and completed &NMN High Performer.
Who Should Use &NMN High Performer?
OUR SCIENTISTS
Dr. Kei Yamana, Ph.D.
CTO, NOMON & Co.
With over 20 years of experience in pharmaceutical research, Dr. Yamana is a leading expert in the medical field. He directs pioneering research on aging and NMN, while also spearheading the development of innovative products and services that integrate cutting-edge science into everyday life.
Dr. Yamana earned his Ph.D. in Human Sciences from the University of Tsukuba and studied at Harvard Medical School and School of Dental Medicine for two years in 2008
Dr. Masanobu Kanou, Ph.D.
Pharmacist, Sports Pharmacist CCO, NOMON & Co.
Dr. Kanou has extensive experience in pharmaceutical research, focusing on pharmacokinetics and the development of therapies for lifestyle -related and muscular diseases.
He currently leads research and support initiatives aimed at expanding the potential of nutraceuticals centered on NMN, with a particular focus on recover y and performance for professional athletes.
Dr. Ryota Nakajima, Ph.D.
Pharmaceutical Science CPO, NOMON & Co.
Dr. Nakajima has over 16 years of experience specializing in drug discovery science and process chemistry, engaging in pharmaceutical research from early-stage exploration through scale-up studies. At NOMON & Co., he oversees the development of new products to promote the societal adoption of NMN, as well as managing manufacturing quality control to ensure safe and reliable supply.
Why NOMON & Co.’s NMN Is the Choice for True Quality
<NOMON & Co.’s Commitment to Quality>
1
Clinically Tested NMN for Proven Human Safety
2
End-to-End Transparency from NMN Raw Material to Final Product
3
Products Developed Based on Fundamental NMN Research
4
Entirely Made in Japan, from Raw Material to Final Product
5
High-Purity NMN Derived from Yeast
6
Plant-Based HPMC Capsules Optimized for NMN Stability
Stable and High Purity NMN — naturally derived from yeast
To ensure safety as natural as our everydayfood,&NMN is crafted from yeast-derivedNMN. With minimal additives, it offers a pure and stable supplement you can trust every day.
FAQ
A: &NMN HIGH PERFORMER is a product that, in addition to NMN (nicotinamide mononucleotide)—the main ingredient of Nadaltus®—includes extra components developed through joint research by NOMON Inc. and Teijin Ltd. to further support NMN.
A: &NMN 60 capsules, 30 capsules, 10 capsules” only contain NMN (nicotinamide mononucleotide) as the main ingredient. &NMN HIGH PERFORMER, on the other hand, combines NMN with additional NMN-supporting ingredients developed through the joint research of NOMON Inc. and Teijin Ltd.
A.
- Chrysanthemum Flower Powder (Luteolin)
Luteolin is the primary component found in chrysanthemum flowers. Commonly known as a yellow pigment, it is one type of flavonoid. - Quercetin Powder
Quercetin is a type of flavonoid with a flavonol structure. It can be found as a glycoside or in free form in many plants, including citrus fruits, onions, and broccoli.
Latest Research
In a 12-week single-arm study, 15 middle-aged Japanese women took 500 mg/day of NMN. Growth of anagen hairs and hair diameter increased, and subjective hair-quality and fatigue scores changed. The findings are preliminary because the trial had no placebo group.
A phase 1/2 trial gave oral NMN for two weeks to 25 adults with steroid-resistant or steroid-dependent immune thrombocytopenia. Five participants, or 20%, met the platelet-response criterion, suggesting an early metabolic approach involving the CD38–NAD+ axis.
A 2026 study gave oral NMN to D-galactose-induced aging-model mice for six weeks and reported improved spatial memory, increased antioxidant enzymes, reduced neuroinflammation, more butyrate-producing bacteria, and activation of Nrf2/HO-1. The findings are preclinical.